Jonathan Youngs
Overview
Explore the profile of Jonathan Youngs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
217
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hurt W, Youngs J, Ball J, Edgeworth J, Hopkins P, Jenkins D, et al.
Thorax
. 2023 Sep;
79(1):75-82.
PMID: 37657925
Background: Invasive pulmonary aspergillosis is a complication of severe COVID-19, with regional variation in reported incidence and mortality. We describe the incidence, risk factors and mortality associated with COVID-19-associated pulmonary...
2.
Frost J, Hamilton F, Arnold D, Elvers K, Shah A, Armitage A, et al.
Wellcome Open Res
. 2022 Aug;
7:173.
PMID: 35935705
Marked reductions in serum iron concentrations are commonly induced during the acute phase of infection. This phenomenon, termed hypoferremia of inflammation, leads to inflammatory anemia, but could also have broader...
3.
McNaughton A, Paton R, Edmans M, Youngs J, Wellens J, Phalora P, et al.
JCI Insight
. 2022 May;
7(13).
PMID: 35608920
The role of immune responses to previously seen endemic coronavirus epitopes in severe acute respiratory coronavirus 2 (SARS-CoV-2) infection and disease progression has not yet been determined. Here, we show...
4.
Pallett S, Wake R, Youngs J, Pope C, Tan N, Taylor J, et al.
Br J Haematol
. 2021 Nov;
196(5):1170-1174.
PMID: 34766331
No abstract available.
5.
Youngs J, Provine N, Lim N, Sharpe H, Amini A, Chen Y, et al.
PLoS Pathog
. 2021 Sep;
17(9):e1009804.
PMID: 34529726
Prior studies have demonstrated that immunologic dysfunction underpins severe illness in COVID-19 patients, but have lacked an in-depth analysis of the immunologic drivers of death in the most critically ill...
6.
Youngs J, Low J, Whitney L, Logan C, Chase J, Yau T, et al.
J Fungi (Basel)
. 2020 Dec;
6(4).
PMID: 33371513
Triazoles remain first-line agents for antifungal prophylaxis in high-risk haemato-oncology patients, but their use is increasingly contraindicated due to drug-drug interactions and additive toxicities with novel treatments. In this retrospective,...
7.
Armstrong-James D, Youngs J, Bicanic T, Abdolrasouli A, Denning D, Johnson E, et al.
Eur Respir J
. 2020 Jul;
56(4).
PMID: 32703771
No abstract available.
8.
Youngs J, Wyncoll D, Hopkins P, Arnold A, Ball J, Bicanic T
J Infect
. 2020 Jun;
81(3):e55-e57.
PMID: 32593654
No abstract available.
9.
Dhariwal A, Youngs J, San Francisco A, Bicanic T
Lancet Infect Dis
. 2020 Feb;
20(2):259.
PMID: 32006514
No abstract available.
10.
Youngs J, Patil S, Jain Y
J Family Med Prim Care
. 2019 Jan;
7(5):982-992.
PMID: 30598944
Background: The cartridge-based nucleic acid amplification test (CBNAAT) Xpert MTB/RIF is more sensitive than smear microscopy for the diagnosis of tuberculosis (TB). It is also more expensive, costing 1450 INR...